Biospace med Wins FDA OK for Imager

The FDA has granted 510(k) clearance to Biospace med of Paris to market its new digital x-ray imager for 2-D use. The EOS 2-D/3-D device offers a low dose of radiation — up to 10 times less than that of current systems — and long-length digital imaging which, combined, permit uninterrupted full-body imaging with a single scan. The instrument performs standing-position imaging, enabling orthopedic surgeons to view the natural alignment of joints.





LATEST NEWS

• Machine Learning Pushes High-Power Lasing Limits
  May 1, 2024
• AmeriCOM Adds President and CEO; AIXTRON SE Appoints Vice President of Investor Relations: People in the News: 5/1/24
  May 1, 2024
• IPG Names Industry Veteran Mark Gitin CEO
  Apr 30, 2024
• 16th Biannual Optatec Conference Continues in Frankfurt
  Apr 30, 2024
• Celestial Surface Mapping Tech Combines Established Techniques
  Apr 30, 2024
• TSMC Partnerships Target Integrated Photonics Capabilities
  Apr 30, 2024
• CLEO Heads to the East Coast
  Apr 29, 2024
• Laser-Based Gas Analyzer Developed to Detect Air Pollution
  Apr 29, 2024